Clinical trial

Zoledronic Acid in MS-patients With Osteoporosis

NCT01166178

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE3

Study timeline

Study start (unknown)2010-10-01Date precision: month

Registry last updated2013-11-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Osteoporosisunresolved

Multiple Sclerosisunresolved

Interventions

Zoledronic AcidDRUG · verified · RxNorm: zoledronic acid

PlaceboDRUG

Calcium and Vitamin D combinationDIETARY_SUPPLEMENT

Sponsors & collaborators

Novartislead sponsor

Mapped research locations

BerlinGermany1 HamburgGermany1 MünchenGermany1 LeipzigGermany1 HeidelbergGermany1 BochumGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01166178 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.